The guidelines for patients’ eligibility for bariatric surgery have not changed since 1991, although recent data suggest there may be indications for broadening application of the surgery.
Do some pernicious patient safety problems remain unresolved, even after systems changes, because health care professionals are not personally held accountable for their failure to meet standards?
A discussion of the ethical issues raised by a patient’s request for off-label, prophylactic bariatric surgery to prevent diabetes mellitus type 2 (DM type 2).
A discussion of the ethical issues raised by a patient’s request for off-label, prophylactic bariatric surgery to prevent diabetes mellitus type 2 (DM type 2).
Does a surgeon’s complication rate in a randomized controlled trial constitute a “significant new finding” that must be reported to patients during the consent process?
Amanda Fakih, MHSA and Kayte Spector-Bagdady, JD, MBE
Testing everyone for everything identifies more fetal conditions, but confusion persists about whether clinicians should leave screening decisions to patients.
AMA J Ethics. 2019; 21(10):E858-864. doi:
10.1001/amajethics.2019.858.
Alysse Gail Wurcel, MD, MS, Jacinda C. Abdul-Mutakabbir, PharmD, MPH, Shira Doron, MD, Christina Yen, MD, and Justin Berk, MD, MPH, MBA
Antimicrobial resistance is a global threat that inequitably affects minoritized populations, including Black, Latinx, and Indigenous people, especially in carceral settings.